Jan Groen is currently the CEO of Novigenix SA in Switzerland and holds a PhD in medical microbiology from the Erasmus University in Rotterdam. He has many years of management experience (VP R&D, COO, CEO) in the life science industry with a focus on emerging technologies, product development and commercialization. Jan has raised over $150 million for both private and public companies, published over 125 scientific papers and holds numerous awards and patents. He is Chairman of the Board of Cergentis BV, and sits on the board of Angle plc in the UK and SPL Medical BV in The Netherlands.
